157 related articles for article (PubMed ID: 26778167)
1. The proprotein convertase PC1/3 regulates TLR9 trafficking and the associated signaling pathways.
Duhamel M; Rodet F; Murgoci AN; Desjardins R; Gagnon H; Wisztorski M; Fournier I; Day R; Salzet M
Sci Rep; 2016 Jan; 6():19360. PubMed ID: 26778167
[TBL] [Abstract][Full Text] [Related]
2. Deciphering molecular consequences of the proprotein convertase 1/3 inhibition in macrophages for application in anti-tumour immunotherapy.
Rodet F; Capuz A; Hara T; van Meel R; Duhamel M; Rose M; Raffo-Romero A; Fournier I; Salzet M
J Biotechnol; 2018 Sep; 282():80-85. PubMed ID: 29990570
[TBL] [Abstract][Full Text] [Related]
3. Proprotein convertase 1/3 (PC1/3) in the rat alveolar macrophage cell line NR8383: localization, trafficking and effects on cytokine secretion.
Gagnon H; Refaie S; Gagnon S; Desjardins R; Salzet M; Day R
PLoS One; 2013; 8(4):e61557. PubMed ID: 23637853
[TBL] [Abstract][Full Text] [Related]
4. Molecular Consequences of Proprotein Convertase 1/3 (PC1/3) Inhibition in Macrophages for Application to Cancer Immunotherapy: A Proteomic Study.
Duhamel M; Rodet F; Delhem N; Vanden Abeele F; Kobeissy F; Nataf S; Pays L; Desjardins R; Gagnon H; Wisztorski M; Fournier I; Day R; Salzet M
Mol Cell Proteomics; 2015 Nov; 14(11):2857-77. PubMed ID: 26330543
[TBL] [Abstract][Full Text] [Related]
5. Paclitaxel Treatment and Proprotein Convertase 1/3 (PC1/3) Knockdown in Macrophages is a Promising Antiglioma Strategy as Revealed by Proteomics and Cytotoxicity Studies.
Duhamel M; Rose M; Rodet F; Murgoci AN; Zografidou L; Régnier-Vigouroux A; Vanden Abeele F; Kobeissy F; Nataf S; Pays L; Wisztorski M; Cizkova D; Fournier I; Salzet M
Mol Cell Proteomics; 2018 Jun; 17(6):1126-1143. PubMed ID: 29531019
[TBL] [Abstract][Full Text] [Related]
6. The activation of liver X receptors inhibits toll-like receptor-9-induced foam cell formation.
Sorrentino R; Morello S; Chen S; Bonavita E; Pinto A
J Cell Physiol; 2010 Apr; 223(1):158-67. PubMed ID: 20049870
[TBL] [Abstract][Full Text] [Related]
7. PIKfyve regulates the endosomal localization of CpG oligodeoxynucleotides to elicit TLR9-dependent cellular responses.
Hazeki K; Uehara M; Nigorikawa K; Hazeki O
PLoS One; 2013; 8(9):e73894. PubMed ID: 24040108
[TBL] [Abstract][Full Text] [Related]
8. Proprotein convertase 1/3 inhibited macrophages: A novel therapeutic based on drone macrophages.
Duhamel M; Rodet F; Murgoci A; Wisztorski M; Day R; Fournier I; Salzet M
EuPA Open Proteom; 2016 Jun; 11():20-22. PubMed ID: 29900108
[TBL] [Abstract][Full Text] [Related]
9. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding.
Molad Y; Pokroy-Shapira E; Carmon V
Innate Immun; 2013 Dec; 19(6):623-30. PubMed ID: 23475790
[TBL] [Abstract][Full Text] [Related]
10. CpG oligonucleotides induce an immune response of odontoblasts through the TLR9, MyD88 and NF-kappaB pathways.
He W; Yu Q; Zhou Z; Wang P
Biochem Biophys Res Commun; 2010 Aug; 399(2):274-8. PubMed ID: 20655295
[TBL] [Abstract][Full Text] [Related]
11. Decreased intracellular TLR9 confers hyporesponsiveness of RAW264.7 cells to subsequent CpG ODN challenge.
Wei L; Hong Z; Jiang Z; Guofu D; Hongwei C; Liangxi W; Yongling L; Bin L; Ping L
Int Immunopharmacol; 2006 Jun; 6(6):935-46. PubMed ID: 16644479
[TBL] [Abstract][Full Text] [Related]
12. [Role and mechanism of signal pathway mediated by Toll-like receptor 9-myeloid differentiation factor 88 in alveolar macrophages in ventilator-induced lung injury in rats].
Dai H; Pan L; Lin F; Ge W; Li W; He S
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2014 May; 26(5):289-93. PubMed ID: 24809254
[TBL] [Abstract][Full Text] [Related]
13. IRAP
Babdor J; Descamps D; Adiko AC; Tohmé M; Maschalidi S; Evnouchidou I; Vasconcellos LR; De Luca M; Mauvais FX; Garfa-Traore M; Brinkmann MM; Chignard M; Manoury B; Saveanu L
Nat Immunol; 2017 May; 18(5):509-518. PubMed ID: 28319098
[TBL] [Abstract][Full Text] [Related]
14. The Role of Proprotein Convertases in the Regulation of the Function of Immune Cells in the Oncoimmune Response.
Rose M; Duhamel M; Rodet F; Salzet M
Front Immunol; 2021; 12():667850. PubMed ID: 33995401
[TBL] [Abstract][Full Text] [Related]
15. CpG-ODN-mediated TLR9 innate immune signalling and calcium dyshomeostasis converge on the NFκB inhibitory protein IκBβ to drive IL1α and IL1β expression.
De Dios R; Nguyen L; Ghosh S; McKenna S; Wright CJ
Immunology; 2020 May; 160(1):64-77. PubMed ID: 32064589
[TBL] [Abstract][Full Text] [Related]
16. Disruption of proprotein convertase 1/3 (PC1/3) expression in mice causes innate immune defects and uncontrolled cytokine secretion.
Refaie S; Gagnon S; Gagnon H; Desjardins R; D'Anjou F; D'Orléans-Juste P; Zhu X; Steiner DF; Seidah NG; Lazure C; Salzet M; Day R
J Biol Chem; 2012 Apr; 287(18):14703-17. PubMed ID: 22396549
[TBL] [Abstract][Full Text] [Related]
17. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
[TBL] [Abstract][Full Text] [Related]
18. Nescient helix-loop-helix 2 interacts with signal transducer and activator of transcription 3 to regulate transcription of prohormone convertase 1/3.
Fox DL; Good DJ
Mol Endocrinol; 2008 Jun; 22(6):1438-48. PubMed ID: 18356286
[TBL] [Abstract][Full Text] [Related]
19. CpG-induced tyrosine phosphorylation occurs via a TLR9-independent mechanism and is required for cytokine secretion.
Sanjuan MA; Rao N; Lai KT; Gu Y; Sun S; Fuchs A; Fung-Leung WP; Colonna M; Karlsson L
J Cell Biol; 2006 Mar; 172(7):1057-68. PubMed ID: 16567503
[TBL] [Abstract][Full Text] [Related]
20. Endoplasmic Protein Nogo-B (RTN4-B) Interacts with GRAMD4 and Regulates TLR9-Mediated Innate Immune Responses.
Kimura T; Endo S; Inui M; Saitoh S; Miyake K; Takai T
J Immunol; 2015 Jun; 194(11):5426-36. PubMed ID: 25917084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
